Amann et al., 2016 - Google Patents
Acute myocardial infarction in the elderly: Treatment strategies and 28‐day‐case fatality from the MONICA/KORA myocardial infarction registryAmann et al., 2016
- Document ID
- 9064170639257424181
- Author
- Amann U
- Kirchberger I
- Heier M
- von Scheidt W
- Kuch B
- Peters A
- Meisinger C
- Publication year
- Publication venue
- Catheterization and Cardiovascular Interventions
External Links
Snippet
Objectives Aim of this observational study was to analyze today's real‐life treatment strategies in elderly patients with an acute myocardial infarction (AMI) and to assess the association between 28‐day‐case fatality and invasive strategy (percutaneous coronary …
- 206010000891 Acute myocardial infarction 0 title abstract description 71
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/328—Health insurance management, e.g. payments or protection against fraud
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
- G06Q50/24—Patient record management
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tsuchihashi-Makaya et al. | Home-based disease management program to improve psychological status in patients with heart failure in Japan | |
| Aldahl et al. | Associations of serum potassium levels with mortality in chronic heart failure patients | |
| Maru et al. | Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort—The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) | |
| Piccini et al. | Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF | |
| Edmondson et al. | Posttraumatic stress due to an acute coronary syndrome increases risk of 42-month major adverse cardiac events and all-cause mortality | |
| Wu et al. | Medication adherence, depressive symptoms, and cardiac event–free survival in patients with heart failure | |
| Aissaoui et al. | Fifteen‐year trends in the management of cardiogenic shock and associated 1‐year mortality in elderly patients with acute myocardial infarction: the FAST‐MI programme | |
| Kuch et al. | 20‐year trends in clinical characteristics, therapy and short‐term prognosis in acute myocardial infarction according to presenting electrocardiogram: the MONICA/KORA AMI Registry (1985–2004) | |
| Scirica et al. | Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial | |
| Amann et al. | Acute myocardial infarction in the elderly: Treatment strategies and 28‐day‐case fatality from the MONICA/KORA myocardial infarction registry | |
| Tveiten et al. | Functioning of long‐term survivors of first‐ever intracerebral hemorrhage | |
| Tian et al. | Clinical profile and prognostic significance of atrial fibrillation in hypertrophic cardiomyopathy | |
| Goulart et al. | Design and baseline characteristics of a coronary heart disease prospective cohort: two-year experience from the strategy of registry of acute coronary syndrome study (ERICO study) | |
| Roos et al. | Investigations, findings, and follow-up in patients with chest pain and elevated high-sensitivity cardiac troponin T levels but no myocardial infarction | |
| Radovanovic et al. | Type 2 myocardial infarction: incidence, presentation, treatment and outcome in routine clinical practice | |
| Khan et al. | Pre‐hospital thrombolysis in ST‐segment elevation myocardial infarction: a regional Australian experience | |
| Antoun et al. | Atrial fibrillation inpatient management patterns and clinical outcomes during the conflict in Syria: An observational cohort study | |
| Gokhroo et al. | Sweating: A Specific Predictor of ST‐Segment Elevation Myocardial Infarction Among the Symptoms of Acute Coronary Syndrome: Sweating In Myocardial Infarction (SWIMI) Study Group | |
| Brown et al. | Racial disparities in cardiovascular risk and cardiovascular care in women | |
| Zègre-Hemsey et al. | Initial ECG acquisition within 10 minutes of arrival at the emergency department in persons with chest pain: time and gender differences | |
| Melgaard et al. | Sex differences in risk of incident venous thromboembolism in heart failure patients | |
| Pinho-Gomes et al. | Characterization of acute heart failure hospitalizations in a Portuguese cardiology department | |
| Eapen et al. | Adherence and persistence in the use of warfarin after hospital discharge among patients with heart failure and atrial fibrillation | |
| Khoshnood et al. | Effects of oxygen therapy on wall‐motion score index in patients with ST elevation myocardial infarction—the randomized SOCCER trial | |
| Chunawala et al. | Prognostic value of shock index in patients admitted with non-ST-segment elevation myocardial infarction: the ARIC study community surveillance |